Elzhina Valium vaginas. 6 vertex units

Description

Composition Active ingredient: Ornidazole – 500 mg; neomycin, neomycin sulfate in the form of – 65,000 IU; prednisolone shaped prednisolone sodium phosphate – 3 mg; econazole in the form of econazole nitrate – 100 mg ;. Excipients: lactose monohydrate – 305.4 mg; potato starch – 90.0 mg; colloidal silicon dioxide – 12.0 mg; povidone (polyvinylpyrrolidone, low molecular weight) – 19.0 mg; crospovidone – 24.0 mg; polysorbate-20 – 3.0 mg; calcium stearate – 12.0 mg; talc – 18.0 mg. Description: The flat oblong tablets with beveled, white or white with a yellowish tinge. Presence of marbling. Product: 500 mg Tablets vaginal 65000 + + IU + 3 mg 100 mg. 3 tablets in blisters of PVC light-shielding film and aluminum foil. 1, 2 or 3 blisters together with instructions for use in a stack of cardboard. Contraindications – hypersensitivity to ornidazole, econazole and other derivatives of imidazole / nitroimidazole, neomycin, and other aminoglycosides, prednisolone, as well as any of the components of the drug; – organic diseases of the central nervous system; – violations of blood; – pregnancy; – the period of breast-feeding; – Children up to age 18 years. Be wary – impaired liver function; – alcoholism. Indications – bacterial vaginitis caused by pyogenic banal flora; – vulvovaginitis, caused by fungi of the genus Candida; – vaginitis caused by mixed infection. Interaction with other drugs Drug Interactions Elzhina drug in intravaginal application has not been studied. Despite the fact that the active components included in the composition of vaginal tablets, absorbed significantly, patients receiving oral anticoagulants, such as warfarin, acenocoumarol and must be careful to follow the coagulation parameters. It is recommended to inform the doctor about the simultaneous treatment with other drugs. Overdosing In overdose intravaginal application unlikely. When accidentally taking the drug orally, the following symptoms: loss of consciousness, headache, dizziness, tremors, convulsions, nausea, vomiting, diarrhea. Treatment: symptomatic therapy. Pharmacological Therapeutic effect: combined antimicrobial agent (antimicrobial agent and protivoprotozoynoe + + aminoglycoside antibiotic-antimycotic agent glucocorticosteroid +). Pharmacodynamics: Elzhina® – combined preparation with antibacterial, antifungal and antiinflammatory action for local application in gynecology. Ornidazole – protivoprotozoynoe agent with antimicrobial activity. Ornidazole is effective against Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia (Giardia intestinalis), and also some anaerobic bacteria such as Bacteroides spp. and Clostridium spp., Fusobacterium spp. and anaerobic cocci: Peptostreptococcus spp. The mechanism of action is due to inhibition of DNA synthesis and structure damage pathogens. Neomycin – a broad spectrum antibiotic aminoglycoside. It is active against a number of gram-positive and gram-negative aerobic microorganisms. Resistance of microorganisms to neomycin develops slowly and to a small extent. It is practically not absorbed through the mucous membranes. Econazole combines the antifungal activity against dermatophytes Trichophyton spp., Microsporum spp., Epidermophyton spp., Yeasts and yeast-like fungi of the genus Candida with antibacterial activity against Gram-positive bacteria Staphylococcus spp., Streptococcus spp. The mechanism of action is to suppress the synthesis of ergosterol cell membrane of fungi. Acts fungicidal and bactericidal. Prednisolone – dehydrated analogue of hydrocortisone, anti-inflammatory, anti-allergic and antipruritic effect. Contributes to the rapid decrease itching and burning. Pharmacokinetics When intravaginal application systemic absorption of active ingredients is low, the drug is practically not absorbed from the surface of the vaginal mucosa. Pregnancy and lactation The drug is contraindicated Elzhina®. Conditions of supply of pharmacies by prescription. Side effects Skin and subcutaneous tissue disorders: angioedema, urticaria, contact dermatitis, skin desquamation and erythema. General disorders and administration site reactions: burning, pain, irritation and swelling at the injection site, vaginal dryness (especially at the beginning of treatment). If any of these instructions side effects are compounded, or if you notice any other side effects not mentioned in the instructions, tell your doctor. Cautions Tablets vaginal Elzhina intended only for intravaginal use, do not apply inside. Despite the fact that in clinical trials showed no changes in the blood system during treatment with Elzhina, it can not be applied to patients with diseases of the hematopoietic system (leukemia, hematopoietic disorders) currently or history. In treating drug Elzhina caution in patients with diseases of the central nervous system. To reduce the risk of recurrence of the disease to the simultaneous treatment of sexual partner. During treatment, it is recommended to select reliable methods of contraception. During the treatment should refrain from sexual intercourse. In the event of a pronounced irritation necessary to stop treatment. Read the instructions carefully before you start using the product. Keep these instructions, it may be needed again. If you have any questions, consult your doctor. Medications that you are treated, you personally designed, and should not be transferred to other persons, because it may harm them even if you have the same symptoms that you have. Effects on ability to drive vehicles and mechanisms of drug Elzhina does not affect the ability to drive vehicles or to engage in other potentially hazardous activities that require high concentration and psychomotor speed reactions. Storage Store in the dark place at a temperature not higher than 25 ° C. Keep out of the reach of children. Dosing and dose Intravaginal. Vaginal tablets to be administered deep into the vagina in the “lying” at the back, after the sanitary treatment of external genital organs. Before introduction into the vagina necessary to hold the tablet in cold boiled water for 20-30 seconds. After administration, tablets must lie within 10-15 minutes. Applied vaginally one vaginal tablet daily at bedtime. The average duration of treatment – 6-9 days. During menstruation Elzhina drug is used in the usual way. If after treatment there is no improvement or there are new symptoms, you should consult with your doctor. Info appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist Info appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist Info appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist